Fresh Equities
ASX:AC8

ASX:AC8

AUSCANN GROUP HOLDINGS LTD

AUSCANN GROUP HOLDINGS LTD has not announced any current capital raises, but we are collecting interest for future raises.

Demand Registered for Next Raise
< $50k
Investors Interested in Next Raise
< 10
How Fresh Equities Works
Authentication

1. Create Account

Complete your onboarding digitally in less than 3 minutes.

Authentication

2. View Terms

View the full term sheet for the capital raise.

Authentication

3. Bid for Allocation

Submit and track your bid online.

Capital Raise History

Fresh Equities does not have AUSCANN GROUP HOLDINGS LTD capital raise history data.


Company Overview

AusCann Group Holdings Ltd (AC8, formerly TW Holdings Limited) a Perth-based company with the aim of producing and providing quality, economical and clinically validated cannabis medicines. Former Names Adelaide Share Investments Limited (ALI), 01/02/2002; Cockatoo Ridge Wines Limited, 10/12/2010; CRW Holdings Ltd (CKR), 23/06/2011; CRW Holdings Limited (CRW), 14/12/2011; TW Holdings Limited (TWH), 25/01/2017

Type

Listed Company

GICS Sub-industry

Pharmaceuticals

Head Office

57 Shenton Ave, Joondalup WA 6027, Australia

Pharmaceuticals
Health Care
Biotech & Health

Price Chart


Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.

Loading...


Directors

Fresh Equities does not have AUSCANN GROUP HOLDINGS LTD directors data.


Announcements

All
All Time
  • AusCann Releases Low-dose Form Capsule on 17 February 2020

    Progress Report

  • December 2019 Quarterly Activities and Cashflow Reports on 29 January 2020

    Commitments test entity quarterly reports

  • Final Director's Interest Notice - C. Edwardes on 19 January 2020

    Shareholder Details

    Appendix 3B on 23 December 2019

    Issued Capital

    Initial Director's Interest Notice x 2 on 20 December 2019

    Shareholder Details

    New Chairman and Independent Director Appointments on 20 December 2019

    Company Administration

  • AusCann Releases Hard-shell Capsules to Clinical Evaluation on 17 December 2019

    Progress Report

  • AC8 Reinstated on Pershing Securities Trading Cannabis List on 12 December 2019

    Company Administration

    Initial Director's Interest Notice - C. Mews on 1 December 2019

    Shareholder Details

    Results of Annual General Meeting on 29 November 2019

    Notice Of Meeting

    Load More

News

Fresh Equities does not have AUSCANN GROUP HOLDINGS LTD news data.